pentoxifylline has been researched along with Lung Diseases, Obstructive in 6 studies
Lung Diseases, Obstructive: Any disorder marked by obstruction of conducting airways of the lung. AIRWAY OBSTRUCTION may be acute, chronic, intermittent, or persistent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pentoxifylline was significantly more effective than the placebo in increasing both the initial and absolute claudication distance (ICD and ACD) in patients with peripheral chronic occlusive arterial disease (COAD)." | 3.76 | Pentoxifylline (Trental)--a new drug for the treatment of peripheral chronic occlusive arterial disease. ( Aggarwal, KK; Chopra, HK; Chopra, KL; Parashar, SK, 1988) |
| "Pentoxifylline has been reported previously in an unblinded study to improve oxygen saturation, treadmill walk time, and resting diffusion of carbon monoxide (Dco) in patients with COPD." | 2.68 | The effects of pentoxifylline on oxygenation, diffusion of carbon monoxide, and exercise tolerance in patients with COPD. ( Causing, LA; Light, RW; Sasse, SA; Stansbury, DW, 1995) |
| "Pentoxifylline is a xanthine derivative with hemorrheologic and vascular properties that may improve gas exchange in patients with chronic obstructive pulmonary disease (COPD)." | 2.67 | Pentoxifylline improves pulmonary gas exchange. ( Axen, K; Bevelaqua, F; Haas, F; Levin, N; Pineda, H; Reggiani, JL; Salazar-Schicchi, J, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (50.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Venugopal, C | 1 |
| Mariappan, N | 1 |
| Holmes, E | 1 |
| Kearney, M | 1 |
| Beadle, R | 1 |
| Sasse, SA | 1 |
| Causing, LA | 1 |
| Stansbury, DW | 1 |
| Light, RW | 1 |
| Haas, F | 1 |
| Bevelaqua, F | 1 |
| Levin, N | 1 |
| Salazar-Schicchi, J | 1 |
| Reggiani, JL | 1 |
| Axen, K | 1 |
| Pineda, H | 1 |
| Chopra, HK | 1 |
| Chopra, KL | 1 |
| Aggarwal, KK | 1 |
| Parashar, SK | 1 |
| Kishi, F | 1 |
| Nishiura, Y | 1 |
| Kamada, A | 1 |
| Kawakami, Y | 1 |
| Coccheri, S | 1 |
| Sturani, C | 1 |
| Palareti, G | 1 |
| Torricelli, P | 1 |
1 review available for pentoxifylline and Lung Diseases, Obstructive
| Article | Year |
|---|---|
Pentoxifylline (Trental)--a new drug for the treatment of peripheral chronic occlusive arterial disease.
Topics: Administration, Oral; Adult; Aged; Arterial Occlusive Diseases; Clinical Trials as Topic; Female; Hu | 1988 |
3 trials available for pentoxifylline and Lung Diseases, Obstructive
| Article | Year |
|---|---|
The effects of pentoxifylline on oxygenation, diffusion of carbon monoxide, and exercise tolerance in patients with COPD.
Topics: Carbon Monoxide; Cross-Over Studies; Double-Blind Method; Exercise Tolerance; Forced Expiratory Volu | 1995 |
Pentoxifylline improves pulmonary gas exchange.
Topics: Adult; Aged; Female; Forced Expiratory Volume; Heart Rate; Humans; Lung Diseases, Obstructive; Male; | 1990 |
Pentoxifylline (Trental)--a new drug for the treatment of peripheral chronic occlusive arterial disease.
Topics: Administration, Oral; Adult; Aged; Arterial Occlusive Diseases; Clinical Trials as Topic; Female; Hu | 1988 |
3 other studies available for pentoxifylline and Lung Diseases, Obstructive
| Article | Year |
|---|---|
Effect of potential therapeutic agents in reducing oxidative stress in pulmonary tissues of recurrent airway obstruction-affected and clinically healthy horses.
Topics: Animals; Bronchodilator Agents; Female; Horse Diseases; Horses; Lung; Lung Diseases, Obstructive; Ma | 2013 |
Pharmacological effects on hemoglobin-oxygen affinity in vitro and in patients with chronic obstructive pulmonary disease.
Topics: Carbon Dioxide; gamma-Aminobutyric Acid; Humans; Hydrogen-Ion Concentration; Kinetics; Lung Diseases | 1988 |
[Effect of pentoxifylline on pulmonary hemodynamics].
Topics: Hemodynamics; Humans; Lung Diseases, Obstructive; Pentoxifylline; Prostaglandins; Pulmonary Circulat | 1988 |